Rockefeller Capital Management’s BioTelemetry, Inc. BEAT Stock Holding History

Rockefeller Capital Management’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-242	Closed	-$17K	–	3485
2020 Q4	$17K	Hold	242	–	–	﹤0.01%	2078
2020 Q3	$11K	Buy	242 +42	+21%	+$1.76K	﹤0.01%	1998
2020 Q2	$9K	Hold	200	–	–	﹤0.01%	1942
2020 Q1	$8K	Hold	200	–	–	﹤0.01%	1836
2019 Q4	$9K	Buy	+200	New	+$8.66K	﹤0.01%	1653
2019 Q2	–	Sell	-286	Closed	-$18K	–	2127
2019 Q1	$18K	Hold	286	–	–	﹤0.01%	1296
2018 Q4	$17K	Hold	286	–	–	﹤0.01%	640
2018 Q3	$18K	Hold	286	–	–	﹤0.01%	524
2018 Q2	$13K	Buy	+286	New	+$11.4K	﹤0.01%	571

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Rockefeller Capital Management's BEAT Position: Q1 2021 in Review

Rockefeller Capital Management sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 242 shares — an estimated $17K sold.

Rockefeller Capital Management first reported a position in BEAT in Q2 2018 and held it in 9 quarters. The position peaked at $18K in Q1 2019. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

Rockefeller Capital Management reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
Rockefeller Capital Management sold 242 BioTelemetry, Inc. shares in Q1 2021, an estimated $17K.
Rockefeller Capital Management first reported a position in BioTelemetry, Inc. in Q2 2018 and held it in 9 quarters.
Rockefeller Capital Management's BioTelemetry, Inc. position peaked at $18K in Q1 2019.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Rockefeller Capital Management's 13F filing for Q1 2021, filed 11 May 2021.